Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. Navab M, et al. Among authors: fogelman am. J Lipid Res. 2004 Jun;45(6):993-1007. doi: 10.1194/jlr.R400001-JLR200. Epub 2004 Apr 1. J Lipid Res. 2004. PMID: 15060092 Free article. Review.
Oxidized lipids as mediators of coronary heart disease.
Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM. Navab M, et al. Among authors: fogelman am. Curr Opin Lipidol. 2002 Aug;13(4):363-72. doi: 10.1097/00041433-200208000-00003. Curr Opin Lipidol. 2002. PMID: 12151851 Review.
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. Navab M, et al. Among authors: fogelman am. Curr Opin Investig Drugs. 2003 Sep;4(9):1100-4. Curr Opin Investig Drugs. 2003. PMID: 14582455 Review.
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. Ansell BJ, et al. Among authors: fogelman am. Circulation. 2003 Dec 2;108(22):2751-6. doi: 10.1161/01.CIR.0000103624.14436.4B. Epub 2003 Nov 24. Circulation. 2003. PMID: 14638544 Clinical Trial.
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM. Navab M, et al. Among authors: fogelman am. Circulation. 2004 Jun 29;109(25):3215-20. doi: 10.1161/01.CIR.0000134275.90823.87. Epub 2004 Jun 14. Circulation. 2004. PMID: 15197147
Anti-inflammatory properties of HDL.
Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. Ansell BJ, et al. Among authors: fogelman am. Rev Endocr Metab Disord. 2004 Dec;5(4):351-8. doi: 10.1023/B:REMD.0000045107.71895.b2. Rev Endocr Metab Disord. 2004. PMID: 15486468 Review. No abstract available.
297 results